MR MELLICENSE: continuous blood glucose measurement arm (Q139379)

From EU Knowledge Graph
Revision as of 12:10, 20 July 2020 by Admin (talk | contribs) (‎Changed claim: summary (P836): R & D & I project involving 3 SMEs and one laboratory on the establishment of a continuous blood glucose measurement arm to allow better monitoring of patients with diabetes, improve their quality of life and reduce complications.)
Jump to navigation Jump to search
Project in France financed by DG Regio
Language Label Description Also known as
English
MR MELLICENSE: continuous blood glucose measurement arm
Project in France financed by DG Regio

    Statements

    0 references
    401,707.49 Euro
    0 references
    856,266.95 Euro
    0 references
    46.91 percent
    0 references
    1 July 2016
    0 references
    30 June 2019
    0 references
    VALOTEC
    0 references
    0 references

    48°47'38.04"N, 2°21'43.06"E
    0 references
    94800
    0 references
    Projet de RDI associant 2 PME et un laboratoire sur la mise en place d'un brassard de mesure du taux de glycémie en continu afin de permettre un meilleur suivi des patients atteint de diabète, d'améliorer leur qualité de vie et réduire les complications. (French)
    0 references
    R & D & I project involving 3 SMEs and one laboratory on the establishment of a continuous blood glucose measurement arm to allow better monitoring of patients with diabetes, improve their quality of life and reduce complications. (English)
    0 references
    Mellisim is designing and testing a new biosensor and a smartphone app to help type two diabetes patients. (English)
    Mellisim & Mellisense
    0 references

    Identifiers

    114
    0 references
    5359
    0 references